107
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Distinct symptom experiences in subgroups of patients with COPD

, , , , , & show all
Pages 1801-1809 | Published online: 02 Aug 2016

References

  • LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
  • MurrayCJLLopezAMeasuring the global burden of diseaseN Engl J Med2013369544845723902484
  • CommitteeGSGlobal strategy for the diagnosis, management and prevention of COPD (Updated 2015)Global Initiative for Chronic Obstructive Lung Disease, Inc serial on the Internet2015 Available from: http://www.goldcopd.orgAccessed April 7, 2015
  • LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
  • BlindermanCDHomelPBillingsJATennstedtSPortenoyRKSymptom distress and quality of life in patients with advanced chronic obstructive pulmonary diseaseJ Pain Symptom Manage200938111512319232893
  • BorgeCRWahlAKMoumTAssociation of breathlessness with multiple symptoms in chronic obstructive pulmonary diseaseJ Adv Nurs201066122688270020825511
  • BurgelPRPaillasseurJLRocheNIdentification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbiditiesBiomed Res Int201420149 Article ID 420134
  • Lopez CamposJBustamanteVMuñozXBarreiroEMoving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine – a critical viewCOPD201411559160224914771
  • VestboJCOPD: definition and phenotypesClin Chest Med20143511624507832
  • GagnonPCasaburiRSaeyDCluster Analysis in patients with GOLD 1 chronic obstructive pulmonary diseasePLoS One2015104e012362625906326
  • Garcia-AymerichJGómezFPBenetMIdentification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax201166543043721177668
  • ChenC-ZWangL-YOuC-YLeeC-HLinC-CHsiueT-RUsing cluster analysis to identify phenotypes and validation of mortality in men with COPDLung2014192688989625288484
  • BurgelP-RPaillasseurJ-LPeeneBTwo distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortalityPLoS One2012712e5104823236428
  • JoKWRaSWChaeEJThree phenotypes of obstructive lung disease in the elderlyInt J Tuberc Lung Dis201014111481148820937191
  • RennardSILocantoreNDelafontBIdentification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysisAnn Am Thorac Soc201512330331225642832
  • ParkSMeldrumCLarsonJSubgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary diseaseHeart Lung201342646547224054947
  • BauseweinCBoothSGyselsMKuhnbachRHaberlandBHigginsonIJUnderstanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancerJ Palliat Med20101391109111820836635
  • JoshiMJoshiABartterTSymptom burden in chronic obstructive pulmonary disease and cancerCurr Opin Pulm Med20121829710322262138
  • ParkSLarsonJSymptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary diseaseJ Clin Nurs20142317–182658267124460846
  • PortenoyRKThalerHTKornblithABThe Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressEur J Cancer199430A9132613367999421
  • MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
  • BestallJPaulEGarrodRGarnhamRJonesPWedzichaJUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
  • SanghaOStuckiGLiangMHFosselAHKatzJNThe Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services researchArthritis Rheum200349215616312687505
  • QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoiresATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
  • O’DonnellDECiavagliaCENederJAWhen obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequencesAnn Am Thorac Soc201411463564424625243
  • ChangVTHwangSSThalerHTKasimisBSPortenoyRKMemorial symptom assessment scaleExpert Rev Pharmacoecon Outcomes Res20044217117819807521
  • EckerbladJTodtKJakobssonPSymptom burden in stable COPD patients with moderate or severe airflow limitationHeart Lung201443435135724856227
  • JonesPWQuirkFHBaveystockCMThe St George’s Respiratory QuestionnaireRespir Med199185suppl Bs25s31
  • Domingo-SalvanyALamarcaRFerrerMHealth-related quality of life and mortality in male patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166568068512204865
  • JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
  • JonesPWInterpreting thresholds for a clinically significant change in health status in asthma and COPDEur Respir J200219339840411936514
  • StåhlELindbergAJanssonSAHealth-related quality of life is related to COPD disease severityHealth Qual Life Outcomes200535616153294
  • MuthenBSheddenKFinite mixture modeling with mixture outcomes using the EM algorithmBiometrics199955246346911318201
  • VermuntJMagdisonJApplied Latent Class AnalysisNew York, NYCambridge University Press2002
  • CollinsLMLanzaSTLatent Class and Latent Transition Analysis: with Applications in the Social, Behavioral, and Health SciencesHoboken, NJJohn Wiley & Sons2010
  • NylundKBellmoreANishinaAGrahamSSubtypes, severity, and structural stability of peer victimization: what does latent class analysis say?Child Dev20077861706172217988316
  • NylundKLAsparouhovTMuthénBODeciding on the number of classes in latent class analysis and growth mixture modeling: a monte carlo simulation studyStruct Equ Modeling2007144535569
  • CeleuxGSoromenhoGAn entropy criterion for assessing the number of clusters in a mixture modelJ Classif1996132195212
  • MuthénLKMuthénBOMplus User’s Guide7th edLos Angeles, CAMuthén & Muthén19982015
  • BentsenSBMiaskowskiCRustoenTDemographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary diseaseQual Life Res201423399199823999743
  • MiaskowskiCDunnLRitchieCLatent class analysis reveals distinct subgroups of patients based on symptom occurrence and demographic and clinical characteristicsJ Pain Symptom Manage2015501283725647419
  • MiaskowskiCCooperBMeliskoMDisease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapyCancer2014120152371237824797450
  • SørheimI-CJohannessenAGulsvikABakkePSSilvermanEKDeMeoDLGender differences in COPD: are women more susceptible to smoking effects than men?Thorax201065648048520522842
  • ForemanMGZhangLMurphyJEarly-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene StudyAm J Respir Crit Care Med2011184441442021562134
  • PumarMIGrayCRWalshJRYangIARollsTAWardDLAnxiety and depression-Important psychological comorbidities of COPDJ Thorac Dis20146111615163125478202
  • Di MarcoFVergaMReggenteMAnxiety and depression in COPD patients: the roles of gender and disease severityRespir Med2006100101767177416531031
  • PanagiotiMScottCBlakemoreACoventryPAOverview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis201491289130625419126
  • BaxterAJScottKMFerrariAJNormanREVosTWhitefordHAChallenging the myth of an “epidemic” of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010Depress Anxiety201431650651624448889
  • ChristensenHJormAFMackinnonAJAge differences in depression and anxiety symptoms: a structural equation modelling analysis of data from a general population samplePsychol Med199929232533910218924
  • HinzAKittelJKaroffMDaigIAnxiety and depression in cardiac patients: age differences and comparisons with the general populationPsychopathology201144528929521659790